NYSEAMERICAN:NHS Neuberger Berman High Yield Strategies Fund (NHS) Stock Price, News & Analysis $5.58 +0.09 (+1.64%) Closing price 11/6/2026 04:10 PM EasternExtended Trading$5.58 0.00 (-0.09%) As of 11/6/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendNews and TrendsOwnershipSEC FilingsShort Interest About Neuberger Berman High Yield Strategies Fund Stock (NYSEAMERICAN:NHS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get NHS alerts:Sign Up Key Stats Today's Range$5.51▼$5.5850-Day Range$5.30▼$5.9752-Week Range$5.26▼$7.75Volume114,023 shsAverage Volume315,951 shsMarket Capitalization$175.16 millionP/E RatioN/ADividend Yield19.53%Price TargetN/AConsensus RatingN/A Company Overview Neuberger Berman High Yield Strategies Fund is a closed-end investment company listed on the NYSE American under the ticker symbol NHS. The fund seeks to provide a high level of current income and, as a secondary objective, capital appreciation by investing primarily in high-yield debt securities. The fund’s portfolio generally includes corporate bonds and other fixed-income securities rated below investment grade or considered comparable to below-investment-grade securities. These investments may be issued by companies in a range of industries and may include securities issued by U.S. and non-U.S. companies. Because of its focus on lower-rated credit, the fund is exposed to increased credit and default risk compared with funds that invest primarily in investment-grade securities. Neuberger Berman High Yield Strategies Fund is managed by investment professionals affiliated with Neuberger Berman, an independent investment management firm. The fund provides investors with a professionally managed vehicle for gaining exposure to the high-yield corporate debt market through a diversified closed-end fund structure.AI Generated. May Contain Errors. Read More Receive NHS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neuberger Berman High Yield Strategies Fund and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NHS Stock News HeadlinesNeuberger High Yield Strategies Fund Inc. Announces Monthly Distribution, Payable on November 30, 2026October 31, 2026 | marketscreener.comMNEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTIONOctober 30, 2026 | prnewswire.comDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall. The free download walks through strategies for navigating the options market, but the window to claim it is closing soon.November 7 at 1:00 AM | TradeWins (Ad)Neuberger High Yield Strategies Fund Inc. Announces A Distribution Declaration, Payable on October 30, 2026September 30, 2026 | marketscreener.comMNEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTIONSeptember 30, 2026 | prnewswire.comOndine shares backed by Peel Hunt as NHS ICU access expandsSeptember 29, 2026 | proactiveinvestors.comOndine Biomedical taps NHS intensive care data to prove Steriwave pays its waySeptember 29, 2026 | proactiveinvestors.comNHS: The High Yield Is Not A Reason To Own This Fund (Rating Downgrade)September 19, 2026 | seekingalpha.comSee More Headlines NHS Stock Analysis - Frequently Asked Questions How have NHS shares performed this year? Neuberger Berman High Yield Strategies Fund's stock was trading at $7.44 on January 1st, 2026. Since then, NHS stock has decreased by 25.0% and is now trading at $5.58. Who are Neuberger Berman High Yield Strategies Fund's major shareholders? Top institutional investors of Neuberger Berman High Yield Strategies Fund include GraniteShares Advisors LLC (1.42%), Shaker Financial Services LLC (0.25%), Total Wealth Planning & Management Inc. (0.20%) and Commonwealth Equity Services LLC (0.07%). View institutional ownership trends. How do I buy shares of Neuberger Berman High Yield Strategies Fund? Shares of NHS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Neuberger Berman High Yield Strategies Fund own? Based on aggregate information from My MarketBeat watchlists, some other companies that Neuberger Berman High Yield Strategies Fund investors own include PIMCO Dynamic Income Fund (PDI), Enterprise Products Partners (EPD), Energy Transfer (ET), Main Street Capital (MAIN), AGNC Investment (AGNC), NVIDIA (NVDA) and Dynex Capital (DX). Company Calendar Record date for 10/30 Dividend10/15/2026Ex-Dividend for 10/30 Dividend10/15/2026Dividend Payable10/30/2026Today11/07/2026Record date for 11/30 Dividend11/16/2026Ex-Dividend for 11/30 Dividend11/16/2026Dividend Payable11/30/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (7m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 NHS's financial health is in the Red zone, according to TradeSmith. NHS has been in this zone for over 7 months. Industry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorFinance Industry Capital Markets Sub-IndustryN/A Current SymbolNYSEAMERICAN:NHS Previous SymbolNYSE:NHS CIK1487610 Webwww.nb.com Phone(212) 476-8800FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares31,390,000Free FloatN/AMarket Cap$175.16 million OptionableNot Optionable Beta0.80 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NYSEAMERICAN:NHS) was last updated on 11/6/2026 by MarketBeat.com Staff. From Our PartnersMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredOne Ticker Tied to a Coming 401k ChangeAn email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will...Brownstone Research | SponsoredTesla pays $0 in dividends. This new fund paid $452 in one month on $5,000.Tesla has never paid shareholders a dividend, not one cent. A new fund built on Tesla's stock takes a differen...Investors Alley | SponsoredLast note from me on thisJoel Peterson's free workshop breaks down a three step, three color system that works across stocks, ETFs, gol...The Cycle Code | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuberger Berman High Yield Strategies Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuberger Berman High Yield Strategies Fund With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.